Cargando…

Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec

Background. In Canada, the current recommendation is to offer PPV23 to adults ≥ 65 years. PCV13 is now licensed for adults. Methods. Invasive pneumococcal disease (IPD) cases in adults 65–74 years of age in the Quebec notifiable diseases registry were classified into five serotype categories. Poisso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Z., Deceuninck, G., Lefebvre, B., De Wals, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299213/ https://www.ncbi.nlm.nih.gov/pubmed/28246534 http://dx.doi.org/10.1155/2017/4347206

Ejemplares similares

Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis
por: Ouldali, Naïm, et al.
Publicado: (2023)

Incidence of Invasive Pneumococcal Disease Before and During an Era of Use of Three Different Pneumococcal Conjugate Vaccines in Quebec
por: De Wals, Philippe, et al.
Publicado: (2017)

Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010
por: Le Meur, Jean-Baptiste, et al.
Publicado: (2014)

The Changing Epidemiology of Meningococcal Disease in Quebec, Canada, 1991–2011: Potential Implications of Emergence of New Strains
por: Gilca, Rodica, et al.
Publicado: (2012)

Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada
por: Longtin, Jean, et al.
Publicado: (2017)

Parental Vaccine Hesitancy in Quebec (Canada)
por: Dubé, Eve, et al.
Publicado: (2016)

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec
por: Montplaisir, Jacques, et al.
Publicado: (2014)

1742 Impact of Material and Social Seprivation on Serogroup B Invasive Meningococcal Disease (IMD-B) Incidence and Outcomes in the Province of Quebec, Canada
por: Tapiero, Bruce, et al.
Publicado: (2014)

Trends of Hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003
por: Canuel, Magalie, et al.
Publicado: (2007)

Burden of respiratory infections and otitis media in the Inuit population of Nunavik, Quebec, Canada
por: De Wals, Philippe, et al.
Publicado: (2020)

Forecast analysis of the incidence of tuberculosis in the province of Quebec
por: Klotz, Alexander, et al.
Publicado: (2013)

99. Presence of Chronic Diseases and Compliance with Québec Provincial Guidelines for Outpatient Antibiotic Prescription, Québec, Canada, 2010-2017
por: Fortin, Elise, et al.
Publicado: (2021)

Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets
por: Law, Dennis K.S., et al.
Publicado: (2015)

Individual and School Correlates of Adolescent Leisure Time Physical Activity in Quebec, Canada
por: Massougbodji, José, et al.
Publicado: (2018)

Recent Trends in Invasive Pneumococcal Disease in Korea in the Post-pneumococcal Vaccine Era
por: Huh, Hee Jae, et al.
Publicado: (2023)

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada
por: Carazo, Sara, et al.
Publicado: (2022)

Tuberculosis in Quebec: a Review of Trends
por: Klotz, Alexander, et al.
Publicado: (2012)

Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults
por: Kuroki, Akane, et al.
Publicado: (2022)

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany
por: van der Linden, Mark, et al.
Publicado: (2015)

1515. Nationwide trends of invasive pneumococcal disease in Spain for the period 2009-2019
por: de Miguel, Sara, et al.
Publicado: (2020)

Homelessness in Adults With Invasive Pneumococcal Disease in Calgary, Canada
por: Lemay, Julie-Anne, et al.
Publicado: (2019)

1105 Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
por: Baxter, Roger, et al.
Publicado: (2014)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore
por: Eng, Philip, et al.
Publicado: (2014)

Middle ear abnormalities at age 5 years in relation with early onset otitis media and number of episodes, in the Inuit population of Nunavik, Quebec, Canada
por: De Wals, P, et al.
Publicado: (2019)

Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System
por: Schulz, Paul S, et al.
Publicado: (2022)

Immunodeficiency Among Children with Recurrent Invasive Pneumococcal Disease
por: Ingels, Helene, et al.
Publicado: (2015)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Temporal trends of alcohol and drug use among Inuit of Northern Quebec, Canada
por: Fortin, Marilyn, et al.
Publicado: (2015)

Effect of childhood pneumococcal vaccination and beta-lactam antibiotic use on the incidence of invasive pneumococcal disease in the adult population
por: Chávez, Abelardo Fernández, et al.
Publicado: (2021)

Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia
por: Narváez, Paula O., et al.
Publicado: (2021)

2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
por: Lewis, Ned, et al.
Publicado: (2019)

70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018
por: Matanock, Almea, et al.
Publicado: (2021)

Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014
por: Kobayashi, Miwako, et al.
Publicado: (2017)

1101 The Gap Widens: Invasive Pneumococcal Serotype Distribution among Adults
por: Grabenstein, John D., et al.
Publicado: (2014)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008)
por: Imöhl, Matthias, et al.
Publicado: (2010)

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017)

1003. Clinical Implications of Emerging Nonvaccine-Serotype Invasive Pneumococcal Disease Among Adults in the Republic of Korea in the Era of Protein-Conjugated Pneumococcal Vaccine
por: Kim, Jong Hun, et al.
Publicado: (2018)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
por: Càmara, Jordi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6hrq4o4re960l7v6j40juhl3g2